Steve Prendeville, Founder and Director of Forte Asset Solutions, speaks to Garry Crole, CEO and Managing Director of Sequoia Financial Group (ASX:SEQ). The discussion touches on the market for financial practices, what advisors can do to prepare their business for sale and what to look out for when acquiring a business, among many other topics.
Copyright 2024 – Finance News Network
Source: Finance News Network
06 Sep 2019 - Argo Investments Limited (ASX:ARG) Managing Director, Jason Beddow talks about the Listed Investment Company’s performance, record low interest rates and finding long-term value.
Read More19 Jun 2023 - Industry standard graphite anodes have reached their technical limitations. AnteoTech Limited (ASX:ADO) CEO and Managing Director David Radford discusses the company's solution for significantly increasing battery capacity by enhancing silicon integration.
Read More23 Apr 2021 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole discusses the company's FY21 profit update and guidance.
Read More17 Mar 2025 - LAG-3 and the Role of Immune Checkpoints in Cancer Treatment
Read More03 Jun 2024 - Cristian Moreno, CEO of Torque Metals (ASX:TOR), discusses the New Dawn Lithium project, the Paris Gold Project and Torque's strategies and future plans.
Read More31 Aug 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discusses new opportunities for the company's automation technology.
Read More18 Aug 2022 - eCargo Holdings Limited (ASX:ECG) Group CEO Lawrence Lun discusses the rationale for the sale of digital consultancy company Amblique, how the proceeds will be used, and the roadmap for the coming months.
Read More24 Oct 2019 - BluGlass Limited (ASX:BLG) Managing Director and CEO, Giles Bourne, discusses the launch of the company's new laser diode business and how this fits into its strategy.
Read More03 Dec 2019 - Noxopharm Limited (ASX:NOX) Executive Chairman & CEO, Dr Graham Kelly, discusses clinical results from the company's Phase 1b clinical DARRT-1 trial for its lead product candidate, Veyonda, with low-dose radiotherapy.
Read More12 Nov 2024 - Dr Chris Burns, the CEO of NOVONIX Limited (ASX:NVX), shares details on a significant supply agreement with Stellantis for synthetic graphite, a milestone for the North American battery market.
Read More
